On April 29th, Yiling Pharmaceutical announced its financial report. In 20021year, the revenue of Yiling Pharmaceutical was10/.1700 million yuan, up15.19% year-on-year; The net profit was 65.438+34.4 million yuan, a year-on-year increase of 654.38+00.27%. However, the first quarterly report of 2022 released by Yiling Pharmaceutical shows that the revenue during the reporting period was 2.722 billion yuan, down 25.80% year-on-year, and the net profit was 484 million yuan, down 28.22% year-on-year.
At the same time, the company's annual report shows that Wu Yiling, the founder of Yiling Pharmaceutical, holds 3 1.53%, Wu Xiangjun, his son, 20.8 1%, Ray Wu, his daughter, 2.34% and Wu Xizhen, his sister, 0.36%. As a concerted action, the Wu family firmly holds the right to speak of Yiling Pharmaceutical, a 10 billion listed company.
According to public information, Wu Yiling, 1949+00 was born in Gucheng County, Hengshui City, Hebei Province in June. The Wu family is a family of traditional Chinese medicine, and Wu's father is famous in the local area. 1977 After resuming the college entrance examination, Wu Yiling was admitted to the Department of Traditional Chinese Medicine of Hebei Medical University. Only one year later, Wu Yiling, a freshman, went directly to Nanjing College of Traditional Chinese Medicine (now Nanjing University of Traditional Chinese Medicine) for postgraduate study. 1982, graduated from Nanjing College of Traditional Chinese Medicine for the first time, and was assigned to work in the Cardiovascular Department of Hebei Provincial Hospital of Traditional Chinese Medicine.
Beijing Youth Daily reporter learned that 1992, Wu Yiling left the hospital and founded a medical research institute in Shijiazhuang High-tech Industrial Development Zone. 1993, Wu Yiling decided to acquire 26 mu of land in the development zone to build its own pharmaceutical factory and hospital. At the beginning of 1995, the pharmaceutical factory was officially put into production, and later Yiling Pharmaceutical came into being.
Yiling pharmaceutical's business map is not just pharmaceutical.
The performance of Yiling Pharmaceutical is mainly driven by its drugs. According to the data, Yiling Pharmaceutical currently owns 13 patented Chinese medicines, of which 8 are listed in the national medical insurance catalogue and 5 are listed in the national essential medicines catalogue.
According to the financial report of Yiling Pharmaceutical, in 20021year, the cardiovascular and cerebrovascular products of Yiling Pharmaceutical performed strongly, that is, Tongxinluo, Shensongyangxin and Qiliqiangxin achieved a total sales income of 4.534 billion yuan, accounting for 44.82% of the revenue, up 3 1.56% year-on-year, and once again became the largest revenue field. As one of the company's main products, in 20021year, Lianhua's plague-clearing products achieved a sales income of 41080,000 yuan, becoming the company's largest single product.
But in fact, the Wu family's business goes far beyond the pharmaceutical industry. The company also has "other patented products" and "other categories" in the financial report, of which the total income of the two categories is 20.210.475 billion yuan, accounting for 14.58% of the total income. In the financial report, a health industry system integrating "medicine, medicine, health and nutrition" and combining online and offline was clearly established. At present, the company has developed and marketed a series of health products, such as mask bead blasting, throat-clearing spray, air herbal sterilization gel and so on, which has a wide range of consumer groups.
In addition, according to the company's annual report and Tian Yan's information, Yiling Pharmaceutical was also involved in the processing and sales of agricultural products, chain pharmacies and hotels, and once owned travel agencies and chain supermarkets.
The second generation of Wu is the "capital" behind Jerry and Luo Yonghao.
Yiling Pharmaceutical is a typical family-owned enterprise. Wu Yiling's son Wu Xiangjun is the general manager of Yiling Pharmaceutical, his daughter Ray Wu is the secretary of the board of directors, and Wu Yiling's nephew Chenguang Li is the chief financial officer of a listed company.
Although there are tens of billions of listed companies, the second generation of the Wu family did not devote themselves to medicine. The Beijing Youth Daily reporter learned that the investment of Wu's second generation spans many industries such as retail, entertainment, education, medical beauty, artificial intelligence and investment.
In the second generation of the Wu family, our son is a person who is more devoted to the family business. It only has shares in Zhejiang Haining Jiahui Investment Partnership (Limited Partnership), a non-family enterprise. This is a company engaged in equity investment, asset management and investment management, with a capital contribution of 1 1 billion yuan. Wu Xiangjun holds 9.09% of the company's shares and is the second largest shareholder of the company together with the other two shareholders. According to the equity penetration chart of Tianyancha, there are three A-share listed companies among the companies invested by Haining Jiahui Investment Partnership. The company also indirectly invested in China Petrochemical Sales Co., Ltd. It is worth mentioning that Luo Yonghao is also favored by Haining Jiahui, who is a shareholder of Hammer Technology (Chengdu) Co., Ltd.
Wu Yiling's daughter Wu Rui owns shares in companies in more fields, including the entertainment industry. According to Tianyan survey, there are currently two film and television companies in Ray Wu, namely Tianjin Le Tong Film and Television Culture Co., Ltd. and Yili Mutual Entertainment (Tianjin) Film and Television Technology Co., Ltd. ..
Tianjin Le Tong Film and Television was founded in March 2006+2065438. It was originally founded by star Jerry and his agent Guo Hongbo. On 20 17, Li XiaoLu and Jerry's sister Jia Shan Qi Xia Company was added as the company's shareholder; From May 2065438 to July 2008, Tianjin Le Tong Film and Television introduced three external investors, Ray Wu being one of them. At present, Ray Wu is still a shareholder of the company, holding 1. 16% of the shares. And the company's current core artist is Jerry.
Chenguang Li has at least 65,438+00 private equity funds or investment institutions. Among them, Teresichuang Equity Investment Partnership (Limited Partnership) in Ningbo Meishan Bonded Port Area invested in Harbin Institute of Technology Robot Group Co., Ltd., and other industries involved include automobile travel, artificial intelligence, education and training.